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ABSTRACT 
 
 
 
 
The aim of this study is to investigate the potential of continuous therapeutic 
ultrasound as an alternative therapy to treat breast cancer disease. The study starts with 
the optimization of the cell seeding numbers, followed by exposure the cells with the 
ultrasound with two different doses, then MTT assay was used to investigate the cells 
viability/toxicity. The doses of therapeutic ultrasound were applied on breast cancer cell 
lines (MCF-7) and normal cell lines (Chinese Hamster Ovary). In this treatment, cells 
were exposed to the therapeutic ultrasound for three days interval. Based on the MTT 
assay, it was revealed that exposure of therapeutic ultrasound shows an inhibition effect 
to MCF-7 cells and less harm on CHO cells. However, when comparing both doses, it 
shows that dose 2 (3MHz, 0.2W/cm2, 10 minutes, continues cycle, distance from the 
bottom to the plate is 0.5 cm) have a better effect than dose 1 (3MHz, 0.1W/cm2, 10 
minutes, continues cycle, distance from the bottom to the plate is 0.5 cm). These results 
indicated that continuous therapeutic ultrasound has an effect in inhibiting the breast 
cancer cells growth and has less harm effect on normal cell. 
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ABSTRAK 
 
 
 
 
Tujuan kajian ini ialah untuk mengkaji potensi terapeutik ultrasound berterusan 
sebagai terapi alternatif untuk mengubati penyakit kanser payudara. Kajian ini 
dimulakan dengan pengoptimuman nombor pengkulturan sel diikuti oleh pendedahan sel 
melalui ultrasound dengan dua dos yang berbeza. Selepas itu, MTT assay telah 
digunakan untuk mengkaji kesan toksik ke atas sel. Dos-dos ultrasound terapeutik telah 
digunakan pada sel kanser payudara (MCF-7) dan sel normal, (Chinese Hamster Ovary 
(CHO)). Dalam kajian ini, sel-sel telah didedahkan kepada ultrasound terapeutik selama 
tiga hari. Berdasarkan kepada MTT assay ia telah menunjukkan bahawa pendedahan 
ultrasound terapeutik menunjukkan kesan perencatan kepada sel-sel MCF-7 dan kurang 
perencatan kepada se-sel CHO. Tetapi, apabila dibandingkan kedua-dua dos ini, ia 
menunjukkan bahawa dos kedu (3 MHz, 0.2W/cm2, 10 minit, kitaran yang berterusan, 
jarak dari bahagian bawah plat adalah 0.5 cm) mempunyai kesan yang lebih baik 
berbanding dengan dos 1 (3MHz, 0.1W/cm2, 10 minit, kitaran yang berterusan jarak dari 
bahagian bawah plat adalah 0.5 cm). Keputusan menunjukkan bahawa ultrasound 
terapeutik berterusan mempunyai kesan dalam merencatkan pertumbuhan sel-sel kanser 
payudara dan kurang perencatan pada sel-sel normal. 
 
 
 
 
 
 
viii 
 
 
 
TABLE OF CONTENTS 
 
 
CHAPTER                                    TITLE                                                            PAGE 
                     TITLE 
                     DECLARATION                                                                              ii 
                     DEDICATION                                                                                 iii 
                     ACKNOWLEDGEMENT                                                              v 
                     ABSTRACT                                                                                     vi 
                     ABSTRAK                                                                                      vii 
                     TABLE OF CONTENTS                                                             viii 
                      LIST OF TABLES                                                                         xi 
                      LIST OF FIGURES                                                                      xii 
          LIST OF ABBREVIATIONS                                                      xv 
          LIST OF APPENDICES          xvi 
 
1 INTRODUCTION                          1 
1.1 Background of Study               1 
1.2 Problem Statement               4 
1.3 Objective of Study               5 
1.4 Scope of Study               5 
1.5 Significance of Study               6 
 
 
 
 
 
 
ix 
 
2 LITERATURE REVIEW                  7 
2.1  Ultrasound                               7 
2.2  Therapeutic ultrasound                                                                                 8 
2.3 Chemotherapy                                                                                               9 
2.3 Radiation therapy                                                                                          10 
2.5  Hormonal therapy                                        10 
2.6  Breast cancer                             11 
2.7  Cell culture                              11 
2.8  Cell lines (MCF-7 and CHO)                           12 
2.8.1  Breast cancer cell line (MCF-7)                                     12 
2.8.2 Chinese Hamster Ovary (CHO)                                     12 
2.9   MTT assay                              13 
 
3 MATERIALS AND METHODS                                  14               
3.1   Materials                   14 
3.1.1 Chemicals and reagents                           14 
3.2   Cell line                   15 
3.3   Solution and Buffer                  15 
3.3.1 Roswell Park Memorial Institute Medium (RPMI 1640)               15 
3.3.2 Phosphate Buffer  Saline                                      15 
3.3.3 MTT reagent                             16 
3.3.4 Dissolving reagent                                                                          16  
3.4   Research methodology                17 
3.4.1 General flow of methodology              17 
3.4.1.1  Subculturing cell lines             18 
3.4.1.2  Optimizing seeding density                        18 
x 
 
3.4.1.3  Exposure of therapeutic ultrasound on normal      19 
                and cancer cells 
3.4.1.4   MTT assay                        20 
3.4.1.5   Statistical analysis                       21 
 
 
4 RESULTS AND DISCUSSION             22 
4.1 Optimization of seeding density            22 
4.2  Ultrasound exposure treatment            29 
4.2.1 Chinese Hamster Ovary cell line (CHO)                     29 
4.2.1.1 Quantitative and qualitative analysis MTT assay  29 
4.2.2 Breast cancer cell line (MCF-7)                       39 
4.2.2.1 Quantitative and qualitative analysis MTT assay  39 
4.3 Percentage inhibition of both cell lines in comparison         48 
4.4 Comparison effect of two dosages of therapeutic ultrasound                  49  
on both cell lines 
4.5 Discussion                        51 
 
5 CONCLUSION AND RECOMMENDATION                    52 
5.1 Conclusion              52 
5.2  Recommendation             53 
       REFERENCES                         54 
       APPENDICES                          61 
 
 
 
 
 
 
 
xi 
 
 
 
LIST OF TABLES 
 
 
TABLE NO.                                         TITLE                                                              PAGE 
3.1  Therapeutic ultrasound doses.    19 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xii 
 
 
 
LIST OF FIGURES 
 
 
FIGURE NO.                                TITLE                                                         PAGE 
 3.1     A diagram of the Sonopuls 491, (Enraf-Nonius, Rotterdam,     20 
    Amsterdam). 
4.1A Optimization of seeding density for CHO cell lines, day 1       23 
 10X magnification. 
4.1B Optimization of seeding density for CHO cell lines, day 2     24 
10X magnification. 
4.1C Optimization of seeding density for CHO cell lines, day 3     25 
10 × magnification. 
4.2A Optimization of seeding density for MCF-7 cell lines, day 1     26 
10 × magnification. 
4.2B Optimization of seeding density for MCF-7 cell lines, day 2     27 
10 × magnification. 
4.2C Optimization of seeding density for MCF-7 cell lines, day 3     28 
10 × magnification. 
4.3 Image of control (A, B, C) and treatment (D, E, F) group of CHO     31 
that treat with dose 1, day 1, under 10 × magnification. 
4.4 Image of control (A, B, C) and treatment (D, E, F) group of CHO      32 
that treat with dose 1, day 2, under 10 × magnification. 
 
 
xiii 
 
4.5 Image of control (A, B, C) and treatment (D, E, F) group of CHO    33 
that treat with dose 1, day 3, under 10 × magnification. 
4.6 Image of control (A, B, C) and treatment (D, E, F) group of CHO    34 
that treat with dose 2, day 1, under 10 × magnification. 
4.7 Image of control (A, B, C) and treatment (D, E, F) group of CHO    35 
that treat with dose 2, day 2, under 10 × magnification. 
4.8 Image of control (A, B, C) and treatment (D, E, F) group of CHO    36 
that treat with dose 2, day 3, under 10 × magnification. 
4.9 Absorbance reading for CHO cell lines that treat with dose 1 in    37 
three days duration. 
4.10 Absorbance reading for CHO cell lines that treat with dose 2 in    37 
three days duration. 
4.11 Percentage of inhibition cell growth for CHO that treat with dose    38 
1 for the over three days.  
4.12 Percentage of inhibition cell growth for CHO that treat with dose    38 
2 for the over three days.  
4.13 Image of control (A, B, C) and treatment (D, E, F) group of     40 
MCF-7 that treat with dose 1, day 1, under 10 × magnification. 
4.14  Image of control (A, B, C) and treatment (D, E, F) group of                 41
 MCF-7 that treat with dose 1, day 2, under 10 × magnification. 
 
4.15 Image of control (A, B, C) and treatment (D, E, F) group of                 42 
MCF-7 that treat with dose 1, day 3, under 10 × magnification. 
 
 
 
 
xiv 
 
4.16  Image of control (A, B, C) and treatment (D, E, F) group of                  43 
MCF-7 that treat with dose 2, day 1, under 10 × magnification. 
 
4.17 Image of control (A, B, C) and treatment (D, E, F) group of                  44 
MCF-7 that treat with dose 2, day 2, under 10 × magnification. 
 
4.18 Image of control (A, B, C) and treatment (D, E, F) group of                  45 
MCF-7 that treat with dose 2, day 3, under 10 × magnification. 
 
4.19 Absorbance reading for MCF-7 cell line that treat with dose 1      46 
(3 MHz, 0.1 W/cm2) in three days duration.  
4.20 Absorbance reading for MCF-7 cell line that treat with dose 2      46 
(3 MHz, 0.2 W/cm2) in three days duration. 
4.21 Percentage of inhibition cell growth for MCF-7 that treat with dose 1   47 
for the over three days. 
4.22 Percentage of inhibition cell growth for MCF-7 that treat with dose 2   47 
for the over three days.  
4.23 Percentage inhibitions of both cell lines that treat with dose 1                48 
for three days.  
4.24 Percentage inhibitions of both cell lines that treat with dose 2                49 
for three days.  
4.25 Comparison effects of two dosages of therapeutic ultrasound                 50 
on MCF-7. 
4.26 Comparison effects of two dosages of therapeutic ultrasound                 50 
on CHO. 
 
 
xv 
 
 
 
LIST OF ABBREVIATIONS 
 
 
CBE   - clinical breast examination 
BSE    -  breast self-examination 
MHz    - Mega Hertz 
W/cm2    - Watt per centimeter square 
MCF-7   - Breast cancer cell line 
CHO    - Chinese Hamster Ovary cell line  
MTT     -  3 - [4,5 - dimethylthiazol-2-yl] -2,5-tetrazolium bromide diphenyl 
nm         -      nanometer 
RPMI 1640     -      Roswell Park Memorial Institute Medium 
FBS    -      Fetal Bovine Serum 
PBS    -      Phosphate Buffer Saline 
Pen Strep  -      Penicillin-Streptomycin 
ATCC       -      American Type Culture Collection 
ml             -      milliliter 
°C              -      degree Celsius (centigrade) 
mg           -      milligram 
µm           -      micrometer 
M               -  Molar 
HCl          -      Hydrochloric acid 
mM      -      milli molar 
CO2        -         Carbon dioxide 
cm         -      centimeter 
µl            -      micro liter 
 
 
xvi 
 
 
 
LIST OF APPENDICES 
 
 
Appendix A  Normality of the data. 
Appendix B  Independent t-test for CHO. 
Appendix C  Independent t-test for MCF-7. 
  
 
CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Background of the study 
 
 
Every year, people are dying from various diseases such as; cardiovascular 
disease, cancer, diabetes and chronic lung diseases and more than 10 million people are 
diagnosed with cancer every year with the rate might increase up to 50% by 2020 
(Luxford et al., 2009). Cancer is an abnormal cell (malignant cells) in the body which 
happen due to the uncontrolled growth (Giuliano et al., 2011). It was reported that every 
year over 1.15 million women in the world are being diagnosed with breast cancer and 
502,000 die from the disease (Montazeri et al., 2008). In Iran, the incidence of the breast 
cancer disease in young age is rising, with advanced stage of the disease (about 10 
years) compare with their western counterparts (Montazeri et al., 2008). 
 
 
Breast cancer is one of the most common disease in females (Montazeri et al., 
2008; Wu et al., 2003) with a life-time risk, 1 out of 8 women diagnosed with breast 
cancer (Montazeri et al., 2008). There are two major types of breast cancer; ductal 
carcinoma and lobular cancer. Ductal carcinoma commence in the tubes which milk 
move from the breast to the nipple, in addition, most breast cancers are occurred based 
on this type. Lobular cancer, commence in lobules that it is part of breast which produce 
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milk (Giuliano et al., 2011; Warner, 2011). However, breast cancer proceed in two 
extensive class; non-invasive and invasive, and breast cancer can commence hardly in 
other location of the breast. Invasive conduct with cancer spreading from milk duct or 
lobule to other tissue in the breast. In contrary, non-invasive means it has not yet 
invaded other breast tissue (Parkin et al., 2005). 
 
 
Early detection of breast cancer is critical for reducing any fatal consequences. 
While screening according to breast self-examine associated with various factors in 
society (age, education, information about breast cancer) and this could control breast 
cancer incidence (Parkin et al., 2005; Montazeri et al., 2008). Symptoms of cancer 
growth may be comprised with changing the shape or size of the breast or nipple, nipple 
discharge, in addition, symptoms in advance breast cancer may be reveal; breast pain, 
bone pain, swelling of in the armpit (Montazeri et al., 2008; Hanan et al ., 2009). 
 
 
Screening Mammography, clinical breast examination (CBE) and breast self-
examination (BSE) has been suggested as an effective method for early detection 
(Montazeri et al., 2008). In addition, screening based on mammogram is an expensive 
method and it is ineffective for female younger than of 50 years (Montazeri et al., 2008). 
A clinical breast examination (CBE) is a simple and inexpensive method to breast 
detection with variable interpersonal interpretation (Jatoi, 2003). For this exam, special 
consideration will be given to abnormalities in shape or size of the breast, changes in the 
skin of the breasts including rashes and redness of nipples for any discharge and area 
under both arms. Then, the examiners concentrate on the location of any lumps of 
softness, and whether such lumps are attached to the skin or to the deeper tissues. 
Nevertheless, it has been shown that the clinical breast exam could detect around 60% of 
breast cancer detected by mammogram and some breast cancers cannot detect by 
mammography (Montazeri et al., 2008; Weiss, 2003). Breast self-examination (BSE) is 
a regular examined by women when they looked and felt both breasts by herself for 
possible lumps (Lam et al., 2008). It is an important way of finding breast cancer at the 
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early stage, when it is more likely to be treated successfully. BSE has conducted with the 
potential of breast cancer detection with less facilities rather than mammography 
(Montazeri et al., 2008). 
 
 
 One of the advance breast cancer treatments is surgery; this method  involves 
removes cancerous tissue which includes lumpectomy and mastectomy. Lumpectomy 
removes the cancerous tumor; anyhow, include normal breast tissue removed around a 
cancerous tissue. In contrary, mastectomy removes all or part of the breast. Further 
advice involves the removal lymph from underarm (axillary) for achieve more 
information on stage of disease (Parkin et al., 2005). For radiation therapy technique 
based on using the X-rays, gamma rays and other radiation sources to kill the cancerous 
cell tissues and shrink the tumors. Radiation therapy may include external beam 
radiation (it comes from a machine outside the body), also called external radiation 
therapy and internal radiation (it comes from radioactive material placed in the body 
near the cancer cells). The side effects of radiation therapy are occurred because high 
doses of radiation used to kill the cancerous cells can also damage healthy cells in the 
treatment area (McGahan et al., 2000). The side effects may be cause extra affect, 
meanwhile, patients also receive chemotherapy, during or after radiotherapy. It shows 
different effect on each person, such as fatigue, vomiting and skin changes that may 
include dryness, and, itching. Many of these side effect features disappear within two 
months after radiation therapy is completed. Furthermore, late side effects may first 
occur six or more months after radiation therapy completely finished (McGahan et al., 
2000). Patients who exposed to radiation may comprise with late side effect, namely, 
infertility, joint problems and mouth problems. Other cancer treatment is chemotherapy 
which related to medication with drugs to treat the cancer. As a result for the side effect 
of chemotherapy, patients lose their hair, loss of appetite, nausea, vomiting, diarrhea, or 
mouth sores. In additional, hormone therapy is a cancer treatment which removes 
hormones or blocks their action and stops cancer cells from growing and the side effect 
of this treatment is like the other (Chlebowski et al., 2010). 
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Recently, a new approach for treating cancer was discovered as another way to 
minimize overall disadvantage of using treatment of surgery, chemotherapy, 
radiotherapy and hormone therapy (Yu et al., 2004; Böhm et al., 2000). Prospective of 
ultrasound for cancer treatment was published in 1933 which conducted with Ehrlich’s 
carcinoma (Haar, 1999; Haar 2007). 
 
 
Therapeutic ultrasound is refers to the mechanical wave that usually used in a 
treatment that specifically for tissue repair (Speed, 2001). It is also, has a different 
approach when compared to the ultrasound imaging that widely use for the pregnancies 
(Haar, 2007). Therapeutic ultrasound frequency has a range 0.75-3 MHz, however most 
ultrasound machines set at a frequency of 1 or 3 MHz (Speed 2001). In this study, the 
approach is to inhibit the growth of cancer cells rather than for the tissue repair. To 
achieve this goal, low frequency of therapeutic ultrasound is used to treat on the breast 
cancer cells. This is because, low frequency of ultrasound waves have greater depth of 
penetration but are less focused. Furthermore, high penetration of ultrasound waves is 
seen in tissue rich in fat (such as breast tissue). This feature can make the therapeutic 
ultrasound is an alternative treatment for breast cancer (Speed 2001; Al-Bataineh et al., 
2011). 
 
 
 
 
1.2 Problem Statement 
 
 
Cancer is a disease where the cells have an abnormal growth. For its treatment, 
the growth of cells should be inhibiting, remove the malignant tumor, suppress the gene 
that code for the cancer and others. Ultrasound treatment may be able to inhibit cancer 
cell growth as an alternative treatment. Thus, a study carried out on the sufficient 
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intensities and frequencies of ultrasound which has more effect on inhibitor breast 
cancer cell growth without or less affecting on other cells. 
 
 
 
 
1.3 Objective of study  
 
 
The overall objectives of the study are: 
 
1) To optimize cell seeding density for normal cell line (CHO) and breast cancer 
cell line (MCF-7). 
 
2) To investigate the effect of two doses of therapeutic ultrasound on MCF-7 
(cancer cell) and CHO (normal). 
 
3) To analyze which dose has a better effect on MCF-7 with no/less harm on CHO 
cells. 
 
 
 
 
1.4      Scope of the study  
 
 
This study was conducted to identify which dose has a better effect to inhibit 
breast cancer cells growth and at the same time has less harm to the normal cells. Cells 
that have been treated with the therapeutic ultrasound will then be analyzed by using the 
MTT assay to check if there is any toxicity or inhibition effect. 
. 
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1.5       Significance of  the study 
 
 
Since breast cancer is one of the leading health threats for human throughout the 
world, the therapeutic ultrasound treatment is expected to be an alternative remedy to 
help in fighting the breast cancer diseases. 
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